BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Eli Lilly Builds Upon Body Of Data For Abemaciclib With Phase III MONARCH 2 Data Demonstrating Superior Progression-Free Survival In Advanced Breast Cancer

  June 5, 2017

   · 

  9 min read
• Drug Development

  Further Study Of Combination Of Eisai Inc.'s Lenvatinib And Merck & Co.'s Pembrolizumab In Previously Treated Patients With Metastatic Endometrial Cancer Supported By Interim Analysis Of Ongoing Phase Ib/II Trial

  June 5, 2017

   · 

  16 min read
• Drug Development

  ARMO BioSciences Announces Promising Response Rates And Survival Data In Patients With Advanced NSCLC And RCC From Phase I/Ib Trial For Immunotherapy AM0010 With Checkpoint Inhibitors

  June 5, 2017

   · 

  7 min read
• Drug Development

  Halozyme Phase II Data In Advanced Pancreas Cancer Featured In An Oral Presentation At ASCO

  June 5, 2017

   · 

  6 min read
• Drug Development

  Bristol-Myers Squibb Release: Encouraging Disease Control Rates Observed With Nivolumab Alone Or In Combination With Ipilimumab In Refractory Or Relapsing Malignant Pleural Mesothelioma Patients: Results From IFCT-1501 MAPS-2 Trial

  June 5, 2017

   · 

  1 min read
• Drug Development

  Phase III Study Showed Genentech’s Alecensa (Alectinib) Reduced The Risk Of Disease Progression Or Death By More Than Half Versus Crizotinib As First-Line Treatment In A Specific Type Of Lung Cancer

  June 5, 2017

   · 

  10 min read
• Genetown

  SAGE Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  June 5, 2017

   · 

  1 min read
• Drug Development

  Zavante Therapeutics Reports ZOLYD Broad Spectrum Activity And Synergy With Multiple Antibiotics; In Vitro Studies Presented At ASM Microbe 2017 Meeting

  June 5, 2017

   · 

  6 min read
• Drug Development

  Helsinn And MEI Pharma Report Correlation Between Mutations In DNA Methylation Pathway And Clinical Response In Phase II Study Of Pracinostat And Azacitidine In Acute Myeloid Leukemia

  June 5, 2017

   · 

  8 min read
• FDA

  Bay Area’s Claret Medical Wins FDA Nod to Market Sentinel Cerebral Protection System in the U.S.

  June 5, 2017

   · 

  4 min read